$DXCM Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of $0.73 up 19.67% YoY
• Reported revenue of $1.34B up 11.18% YoY
• Dexcom raised fiscal year 2026 revenue guidance midpoint to $5.21B, reiterated non-GAAP gross profit margin guidance at approximately 64%, and increased non-GAAP operating margin and Adjusted EBITDA margin guidance to approximately 24% and 32%.